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Abstract 32 
Polyploidy is present in many cancer types and is increasingly recognized as an important 33 
factor in promoting chromosomal instability, genome evolution, and heterogeneity in cancer 34 
cells. However, the mechanisms that trigger polyploidy in cancer cells are largely unknown. In 35 
this study, we investigated the origin of polyploidy in esophageal adenocarcinoma (EAC), a 36 
highly heterogenous cancer, using a combination of genomics and cell biology approaches in 37 
EAC cell lines, organoids, and tumors. We found the EAC cells and organoids present specific 38 
mitotic defects consistent with problems in the attachment of chromosomes to the 39 
microtubules of the mitotic spindle. Time-lapse analyses confirmed that EAC cells have 40 
problems in congressing and aligning their chromosomes, which can ultimately culminate in 41 
mitotic slippage and polyploidy. Furthermore, whole-genome sequencing, RNA-seq, and 42 
quantitative immunofluorescence analyses revealed alterations in the copy number, 43 
expression, and cellular distribution of several proteins known to be involved in the mechanics 44 
and regulation of chromosome dynamics during mitosis. Together, these results provide 45 
evidence that an imbalance in the amount of proteins implicated in the attachment of 46 
chromosomes to spindle microtubules is the molecular mechanism underlying mitotic slippage 47 
in EAC.  Our findings that the likely origin of polyploidy in EAC is mitotic failure caused by 48 
problems in chromosomal attachments not only improves our understanding of cancer 49 
evolution and diversification, but may also aid in the classification and treatment of EAC and 50 
possibly other highly heterogeneous cancers.    51 
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Introduction 52 
Genomic instability drives evolution, diversification, heterogeneity and adaptation in many 53 
cancers.  One type of genomic instability, chromosomal instability (CIN), promotes large scale 54 
structural and numerical genomic changes that can lead to punctuated evolution by producing 55 
abrupt changes in the balance of critical growth and death pathways [1]. CIN is usually 56 
classified as either structural - to indicate alterations in chromosome structure, such as 57 
translocations, inversions, duplications - or numerical - characterized instead by recurrent gain 58 
or loss of chromosomes that lead to aneuploidy and/or polyploidy. Some cancers present one 59 
specific type of CIN, but the two can occur together and numerical CIN can subsequently lead 60 
to structural chromosomal aberrations. Although both aneuploidy and polyploidy are very 61 
common in various cancers and numerical CIN is now considered a key factor in cancer 62 
evolution and diversification, its origin and exact role in cancer onset are still debated [1, 2]. 63 
There is evidence that the presence of extra centrosomes, which is observed in various 64 
cancers, can directly lead to an increase in incorrect (merotelic) attachments of chromosomes 65 
to the spindle microtubules that in turn cause chromosome mis-segregation and aneuploidy [3, 66 
4]. By contrast, our knowledge of the mechanisms that trigger polyploidy in cancer cells is still 67 
poor, despite the evidence that nearly 30% of different cancer types present whole genome 68 
doubling (WGD) events and that polyploidy propagates CIN, accelerates cancer genome 69 
evolution, increases tolerance to chromosome mis-segregation and drug treatments, and is 70 
associated with poor cancer prognosis [5-8]. 71 
Esophageal adenocarcinoma (EAC), the predominant histological type of esophageal 72 
carcinomas in the western world with high mutation burden and substantial heterogeneity [9-73 
12], represents an ideal system to study the origins and role of polyploidy in cancer evolution 74 
and heterogeneity. EAC develops from a pre-cancerous condition known as Barrett’s 75 
esophagus (BE). BE can progress from a non-dysplastic lesion through intermediate stages of 76 
low-grade and high-grade dysplasia leading to EAC formation [13]. During EAC development, 77 
the copy number and heterogeneity of the genome increases and the spectrum of mutations 78 
and rearrangements shows very little overlap with its paired BE counterpart [14]. Whole 79 
genome sequencing (WGS) of paired BE and EAC samples indicated that, although 80 
approximately 80% of point mutations found in EAC samples are already present in the DNA 81 
from the adjacent BE epithelium [15], the difference in copy number aberrations between BE 82 
vs. EAC samples was much more dramatic. BE samples contained very few copy number 83 
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changes and were mostly diploid, whereas EAC showed a wide range of copy numbers changes 84 
including some highly amplified regions [14, 16]. These studies also found that up to two thirds 85 
of EACs emerged following a WGD event (tetraploidy), in a proposed pathway comprising an 86 
initial loss of p53 followed by tetraploidy and subsequent CIN [16]. 87 
There are four events that, in principle, can lead to polyploidy: cell fusion, genome 88 
endoreduplication, cytokinesis failure or mitotic slippage. In the latter case, cells fail to satisfy 89 
the mitotic checkpoint and, after sustaining a prolonged arrest, the chromosomes decondense 90 
without segregating to the poles and cells re-enter in G1 phase. Both cytokinesis failure and 91 
mitotic slippage result in the formation of cells with a polyploid number of chromosomes, but 92 
the first leads to cells containing two equally sized nuclei (binucleate) whereas the second 93 
generally leads to cells with a single, large tetraploid nucleus. As no clear evidence for either 94 
cell fusion or endoreduplication has been reported in BE and EAC, we hypothesized that 95 
genome doubling in EAC development might arise as a result of a defect in cell division. To 96 
address this hypothesis and to understand the origin(s) of polyploidy in EAC, we analyzed cell 97 
division in both a 2D cell system that recapitulate EAC development and in patient-derived 98 
organoids. Our findings indicated that polyploidy in EAC originates from mitotic slippage 99 
caused by failure in chromosome alignment and segregation. Furthermore, WGS, RNA-seq, and 100 
quantitative immunofluorescence analyses suggested that an imbalance in the amount, and 101 
possibly regulation, of proteins involved in the attachment of chromosomes to spindle 102 





p53-deficent BE and EAC cells display specific mitotic defects 108 
As a first step to investigate the potential origin(s) of polyploidy in EAC, we analyzed cell 109 
division in a panel of BE and EAC cultured cells specifically selected in order to recapitulate the 110 
stages of progression from the pre-malignant condition to the carcinoma. We used two BE cell 111 
lines: CPA and CPD; the first is non-dysplastic, near-diploid, and has wild-type p53, while the 112 
second is dysplastic, near tetraploid and have mutated p53. We also analyzed four different 113 
EAC cell lines (all near-tetraploid and p53-deficient) and included the non-transformed 114 
immortalized RPE-1 cell line as a reference control cell line (Supplementary Table S1). To 115 
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analyze mitosis, cells were stained by immunofluorescence for the mitotic marker histone H3 116 
pS10, tubulin and DNA, to calculate the frequency of mitotic cells or mitotic index (MI) and 117 
visualize the mitotic spindle and chromosomes. All BE and EAC cells had an MI lower than the 118 
control RPE1 cells (Fig. 1a). CPA, CPD and FLO cells had very similar MI values at around 4%, 119 
whereas JH-Eso-Ad1 and OE19 had slightly lower MIs, and OE33 cells had the highest MI 120 
among the esophageal cell lines, which was comparable to that of RPE1 cells (Fig. 1a). 121 
Quantification of cells at different mitotic stages (prophase/prometaphase, metaphase, 122 
anaphase and telophase/cytokinesis) revealed some interesting differences (Fig. 1b, 123 
Supplementary Table S2). As expected, in control RPE-1 cells the highest percentage of mitotic 124 
cells were found to be in prophase/prometaphase and telophase/cytokinesis (Fig. 1b). A similar 125 
trend was observed in the two BE cell lines and in OE19, albeit both CPA and CPD had a low 126 
percentage of cells in telophase/cytokinesis (Fig. 1b). By contrast, the other three EAC cell lines 127 
had a higher percentage of cells displaying a metaphase plate with apparently aligned 128 
chromosomes compared to RPE-1 and BE cells, which in FLO and JH-Eso-Ad1 was even higher 129 
than the number of cells in prophase. The combination in these EAC cells of an increase in 130 
metaphase cells without a high MI indicates that they spend long time in a metaphase-like 131 
configuration, possibly because of problems in aligning and/or segregating their chromosomes, 132 
but can then successfully progress through mitosis and the rest of the cell cycle. Immuno-133 
fluorescence analysis also revealed that the p53-deficent CPD and EAC cell lines displayed a 134 
higher frequency of mitotic defects (up to 10%) than RPE-1 and CPA cells (Fig. 1c). A similar 135 
result was observed for the quantification of multinucleate cells (cells containing 2 or more 136 
equally sized nuclei; a readout for cytokinesis failure), although the frequency of this 137 
phenotype was much lower (<1.5%) (Fig. 1d). The mitotic defects were categorized into three 138 
main phenotypes: lagging chromatin/chromosomes, multipolar spindles, and defects in 139 
chromosome congression, characterized by the presence of misaligned chromosomes (Fig. 1e-140 
g, Supplementary Fig S1, Supplementary Table S3). Chromosome congression defects 141 
presented with varying levels of severity; in some cases most chromosomes successfully 142 
aligned at the metaphase plate with just a few uncongressed chromosomes, whereas in other 143 
severe cases all chromosomes failed to congress and were randomly distributed over the 144 
mitotic spindle (Fig. 1f and g). We will hereafter collectively refer to chromosome congression 145 
defects as the ‘scattered chromosomes’ phenotype. This phenotype was one of the most 146 
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frequently observed across all the p53-deficient cell lines and was absent in both RPE-1 and 147 
CPA.  148 
A previous study reported that centrosome amplification occurred early in the progression 149 
of BE into EAC, and that this was dependent upon p53 loss [17]. As supernumerary 150 
centrosomes can cause mitotic defects, we analyzed their presence in our BE cell lines and in 151 
the two EAC cell lines, FLO and JH-Eso-Ad1, that had the highest percentage of mitotic defects 152 
(Fig. 1e). We stained BE and EAC cells with antibodies against Plk4 and γ-tubulin to mark and 153 
quantify centrioles and centrosomes, respectively, and assessed whether extra centrosomes 154 
correlated with multipolar spindles and/or scattered chromosomes (Supplementary Fig. S2). 155 
Both BE cell lines showed only bipolar spindles with two centrosomes and correctly aligned 156 
chromosomes, while FLO and JH-Eso-Ad1 cells had 10-12% of cells with more than two 157 
centrosomes (Supplementary Fig. S2b), which often generated multipolar spindles, but with 158 
properly congressed chromosomes (Supplementary Fig. S2a and S2c). Importantly, scattered 159 
chromosomes were only observed in cells with two centrosomes and bipolar spindles 160 
(Supplementary Fig. S2c). 161 
Together, our results indicate that p53-deficient BE and EAC cells have a significant 162 
increase in cells with misaligned chromosomes that do not appear to be associated with extra 163 
centrosomes and multipolar spindles. 164 
  165 
EAC cells have a functional spindle assembly checkpoint and manifest mitotic slippage 166 
We next employed time-lapse microscopy to better understand the origin of the mitotic 167 
defects in both BE and EAC cells and how they affected progression through mitosis. However, 168 
we first established whether these cell lines had a functional spindle assembly checkpoint 169 
(SAC), the surveillance mechanism that prevents mitotic exit until all chromatids have correct 170 
bipolar attachments [18]. In the presence of a functional SAC, cells arrest in mitosis when 171 
treated with the microtubule depolymerizing drug nocodazole. BE, EAC, and RPE-1 cells 172 
displayed variable increases in MI after nocodazole treatment, clearly indicating that they all 173 
possess a functional SAC (Supplementary Fig. S3). 174 
We incubated CPA, FLO and JH-Eso-Ad1 cells with the SiR-DNA dye to visualize 175 
chromosomes and then recorded images at five-minute intervals for 8 to 10-hour periods to 176 
monitor their progression through mitosis (Fig. 2). As expected, almost all CPA cells (90.0%; 177 
n=30) progressed through mitosis without problems (Fig. 2a, Supplementary Movie 1) and only 178 
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a small percentage of CPA cells showed lagging chromatin or failed cytokinesis (Fig. 2e). Similar 179 
to the results observed in fixed cells, 72% of FLO cells divided normally, while 6% formed 180 
multipolar spindles, 11% lagging chromatin (Fig. 2b, Supplementary Movie 2), and 11% 181 
experienced mitotic slippage (Fig. 2e). In the last case, cells formed a broad metaphase plate, 182 
indicating chromosome congression defects, spent up to three hours in this configuration 183 
without entering anaphase, and then the chromosomes appeared to decondense and a 184 
nucleus reformed (Fig. 2c, Supplementary Movie 3). Mitotic slippage was also observed with 185 
even higher frequency in JH-Eso-Ad1 cells (28.6%; n=7) (Fig. 2d and 2e). Cells that failed to 186 
progress past metaphase appeared to have congressed their chromosomes at the equator, 187 
forming a well-defined metaphase plate, approximately 30 minutes after nuclear envelope 188 
breakdown (NEB), which marks the beginning of prometaphase. The cells then remained in this 189 
phase for about 90 minutes until the chromosomes began to drift away from the metaphase 190 
plate. In extreme cases, like the one showed in Fig. 2d, six hours after NEB the chromosomes 191 
drifted from the metaphase plate and attempted to realign, but failed and by the end of the 192 
recording period (8 hours) the cell begun to decondense the chromosomes, possibly because 193 
of cohesion fatigue (Fig. 2d, Supplementary Movie 4). The number of filmed JH-Eso-Ad1 cells 194 
was lower than the other two cell lines because most of the cells died during or prior to 195 
filming, despite our extensive troubleshooting to establish optimal conditions for these cells. 196 
Our time-lapse experiments allowed us also to calculate the length of mitosis and we 197 
found that EAC cells took at least twice as long to divide than BE cells. Mitosis in CPA cells was 198 
completed in about 1 hour (58 ± 14 minutes), while it took an average of 103 (± 31) minutes in 199 
FLO cells and 212 (± 19) minutes in JH-Eso-Ad1 cells (Fig. 2f). It took also significantly longer for 200 
FLO and JH-Eso-Ad1 cells to reach anaphase onset after NEB than CPA cells (Fig. 2f), indicating 201 
that chromosome congression was more challenging in EAC cells. 202 
In conclusion, these findings indicate that EAC cells have problems in congressing and 203 
aligning chromosomes, which can ultimately cause mitotic slippage and polyploidy. 204 
 205 
EAC organoids display mitotic defects similar to cultured cells  206 
EAC cell lines are the most widely used model for EAC research, but in many cases we lack 207 
genomic information about both their primary tumors and germlines [19]. Moreover, they can 208 
only recapitulate EAC to an extent because culturing them over numerous passages make 209 
them unrepresentative of the mutational features of the original tumor [19]. To overcome 210 
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these limitations, we have recently develop a series of EAC-derived organoids that more 211 
faithfully represent the primary cancers from which they derived and can be stably maintained 212 
[20]. Therefore, we decided to further validate our findings from cultured cell lines by 213 
investigating whether EAC organoids presented similar mitotic defects. 214 
A selection of organoids that represent healthy gastric tissues (NG088) and EACs with 215 
various ploidies and karyotypes (Supplementary Table S4 and Supplementary Fig. S4) were 216 
stained for tubulin, DNA and the centromeric marker CREST [21] to visualize, characterize and 217 
quantify mitotic figures (Fig. 3a). Almost all (95%, n=20) mitotic spindles observed in a normal 218 
gastric organoid line (NG088) were bipolar and had correctly congressed chromosomes (Fig. 3a 219 
and 3b). By contrast, all EAC organoids presented a much higher frequency of abnormal 220 
mitoses than NG088 (Fig. 3b). Similar to the data collected from cell lines, the most prevalent 221 
mitotic aberrations observed in EAC organoids were multipolar spindles and scattered 222 
chromosomes (Fig. 3c). With the exception of organoid CAM423, multipolar spindles were 223 
present in at least 10% of mitoses. The incidence of scattered chromosomes (5-20%) was 224 
sometime lower than multipolar spindles (Fig. 3c), but still comparable to the data obtained 225 
from EAC cell lines (Fig. 1). Interestingly, although these two mitotic defects were observed in 226 
both polyploid and aneuploid EAC organoids, one of the two polyploid organoids, CAM423, did 227 
not show multipolar spindles, while the other, CAM277, had no scattered chromosomes (Fig. 228 
3c).   229 
Together, our findings indicate that EAC organoids present the same types of mitotic 230 
aberrations observed in EAC and BE cell lines. Although we could not find any clear correlation 231 
between mitotic defects and ploidy, the presence of scattered chromosomes did not appear to 232 
depend on the formation of multipolar spindles, which is consistent with the cell line data. 233 
 234 
Whole genome sequencing (WGS) of BE and EAC cell lines and primary tumors shows 235 
numerous copy number changes in kinetochore genes 236 
The presence of chromosome alignment defects in both EAC cells and organoids suggested 237 
that the attachment of chromosome to microtubules might be impaired in these cells. The 238 
centromeric regions of chromosomes attach to microtubules through the kinetochore, a 239 
macromolecular structure composed of a multitude of proteins and protein complexes [22]. 240 
The kinetochore is divided into two layers, the inner and outer kinetochore. The inner 241 
kinetochore comprises many CENP proteins that assemble onto the major centromeric protein 242 
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CENP-A, a centromere-specific variant of histone H3, to form the constitutive centromere-243 
associated network (CCAN) [22]. The outer kinetochore is comprised primarily of the large 244 
multi-subunit Knl1/Mis12/Ndc80 complex network (KMN network), which is recruited by the 245 
CCAN at the inner kinetochore to form strong interactions with mitotic spindle microtubules 246 
[23]. Furthermore, the association of kinetochores to microtubules is finely regulated by 247 
phosphorylation mediated by serine/threonine kinases and counteracting phosphatases, 248 
including Aurora B kinase (AURKB) [24].   249 
We therefore investigated whether EAC cells, organoids, and tumors presented alterations 250 
in the structure and copy numbers of genes that might be responsible for the chromosome 251 
attachment defects observed in EAC cells and organoids. We selected genes encoding proteins 252 
known to be involved in chromosome alignment, including kinetochore components (e.g., 253 
CCAN and KMN proteins), SAC proteins, and regulatory factors, such as AURKB, Polo-like kinase 254 
1 (Plk1), and members of the PP1 and PP2A phosphatase families [22, 25] (Supplementary 255 
Table S5). WGS analyses revealed a number of alterations in our selected gene set that were 256 
shared across cell lines, organoids, and tumors (Fig. 4). The most common feature was gene 257 
amplification, which was frequently observed for the outer kinetochore components Dsn1 and 258 
Ndc80, the SAC proteins Mad1 and Mad2-binding protein MAD2L1BP (also known as p31 259 
comet) [26], and various members of the PP1 family of phosphatases (Fig. 4). The picture for 260 
CCAN inner centromeric proteins (CENPs) was more mixed, with a combination of 261 
amplifications and missense mutations (Fig. 4). RNA-seq analyses confirmed that, in tumors, 262 
gene amplification corresponded to a significant increase in gene expression levels (p-value < 263 
0.0001) for the mostly frequently amplified genes encoding for Dsn1, MAD2L1BP, and the 264 
regulatory PP1 subunit PPP1R1B (Fig. 5a). In many cases, PPP1R1B was over-amplified (ploidy 265 
adjusted copy number > 10), which is particularly interesting considering its close proximity to 266 
the oncogene ERBB2 that is also frequently over-amplified in EACs. Moreover, single sample 267 
gene set enrichment analysis showed a co-enrichment of our gene signatures with known cell-268 
cycle hallmark gene signatures (Fig. 5b). 269 
These findings suggest that alterations in the copy number and expression of genes 270 
involved in chromosome attachment might be connected to the mitotic defects observed in 271 
both cell lines and organoids.   272 
 273 
The expression levels of inner and outer kinetochore components are altered in EAC cells  274 
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The alterations in copy number and expression of our gene set highlighted by the WGS and 275 
RNA-seq analyses prompted us to investigate whether these changes were also reflected at 276 
protein level in BE and EAC cells by both Western blot and immunofluorescence microscopy. 277 
We analyzed the levels of a selection of SAC and kinetochore proteins, BubR1, CENP-C, Dsn1, 278 
Ndc80, and Spc24, in unsynchronized BE and EAC cells by Western blot (Fig. 6a). CPA cells were 279 
used as reference controls because are not dysplastic and have very few copy number changes 280 
[27] (Supplementary Table S1). In agreement with our WGS and RNA-seq results, Western blot 281 
analysis revealed substantial differences in the levels of kinetochore proteins both within 282 
individual cell lines and comparatively across the different BE and EAC cell lines. The levels of 283 
the outer kinetochore components Ndc80 and DSN1 (member of the Mis12 complex) were 284 
increased between two- and four-fold in all cell lines compared to CPA (Fig. 6a). The levels of 285 
the outer kinetochore component Spc24 (member of the Ndc80 complex) and inner 286 
kinetochore component CENP-C showed a more modest increase only in FLO and JH-Eso-Ad1 287 
cells (Fig. 6a). By contrast, the mitotic checkpoint protein BubR1 showed slightly decreased 288 
expression in CPD, FLO, and JH-Eso-Ad1 cells. Interestingly, an additional, slower migrating 289 
BubR1 band was present in CPD and, more weakly, FLO cells, which could represent either a 290 
longer isoform or a specific post translational modification (Fig. 6a).  291 
We next analyzed the accumulation of kinetochore proteins in mitotic cells by 292 
immunofluorescence. The level of each kinetochore protein was normalized to the level of a 293 
centromeric marker derived from human CREST patient serum [21] (see Methods). The 294 
accumulation of Ndc80, Spc24 and BubR1 at kinetochores followed in large part the same 295 
profiles observed in our Western blot analysis (Fig. 6b-d).  Ndc80 intensity was significantly 296 
higher in CPD and FLO cells than in CPA cells, but no significant difference was observed in JH-297 
Eso-Ad1 cells (Fig. 6B). By contrast, accumulation of the other Ndc80 complex subunit, Spc24, 298 
was only reduced in CPD cells, but not in EAC cells, compared to CPA controls (Fig. 6c). In full 299 
accordance with the Western blot analysis, BubR1 levels were reduced in both EAC cell lines 300 
(Fig. 6d). Unfortunately, we failed to obtain a clear BubR1 signal in CPD cells, which might be 301 
possibly related to the presence of an additional band in Western blots (Fig. 6a). In contrast to 302 
the Western blot analysis, the levels of the Mis12 subunit DSN1 were significantly reduced in 303 
all cell lines (Fig. 6e). We then analyzed the levels of AURKB because of its key role in 304 
correcting improper chromosome attachments [24, 28]. AURKB levels were strongly reduced in 305 
both CPD and FLO cells, but not in JH-Eso-Ad1 (Fig. 6f). Finally, comparison between mitoses 306 
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with aligned or scattered chromosomes revealed that the levels of all these kinetochore 307 
proteins were significantly reduced on kinetochores of scattered chromosomes in almost all 308 
EAC cell lines, with the only exception of BubR1 in JH-Eso-Ad1 cells (Fig. 6b-f). 309 
In conclusion, these results indicate that both inner and outer kinetochore proteins show 310 
different expression and kinetochore accumulation levels in dysplastic BE and EAC cells 311 
compared to CPA controls, which is likely to contribute to the defects in chromosome 312 
attachments observed in these cells.  313 
 314 
EAC cells with scattered chromosomes have a significant increase of lateral kinetochore-315 
microtubule attachments  316 
The initial lateral attachments of kinetochores to spindle microtubules are subsequently 317 
converted into end-on attachments [29], which are necessary to impart the pushing and 318 
pulling forces required for chromosome congression [30]. The astrin-SKAP complex is recruited 319 
to mature, end-on kinetochores and is therefore used as a marker of end-on conversion [31]. 320 
To investigate whether the chromosome congression defects observed in EAC cells could result 321 
from a failure in converting lateral to end-on attachments, we stained with antibodies against 322 
astrin to visualize and quantify the different types of kinetochore-microtubule attachments 323 
(Fig. 7a). In both CPA and FLO cells that had successfully congressed to the metaphase plate, 324 
less than 10% of kinetochores were laterally attached (Fig. 7b), whereas there was a two-fold 325 
increase of lateral attachments in FLO cells with scattered chromosomes (Fig. 7b). This data 326 
suggests that a problem in converting from lateral to end-on attachments could be in part 327 
responsible for chromosome congression failure in EAC cells.  328 
 329 
Discussion 330 
The emerging evidence that polyploidy contributes to cancer evolution and heterogeneity by 331 
promoting CIN highlights the need to study the mechanisms that cause genome doubling in 332 
cancers not only to understand its role in cancer biology, but also to aid in the classification 333 
and design of therapeutic treatments of highly heterogeneous cancers. In this study we 334 
present evidence that polyploidy in EAC originates from mitotic slippage caused by defects in 335 
chromosome attachments during mitosis. Importantly, the frequency of these defects, less 336 
than 10% in cells and around 20% in organoids (Figs 1 and 3), is high enough to promote CIN, 337 
but not to significantly affect the viability of the entire cell population. We propose that these 338 
 12
defects may permit the evolution of small clones within the large EAC cell population that can 339 
then more successfully adapt to the selective pressure of changing conditions. 340 
The most prevalent mitotic defect observed in EAC cells was chromosome congression 341 
failure characterized by the presence of misaligned and scattered chromosomes, which is a 342 
phenotype typically caused by defective kinetochores invoking a robust SAC. Structural and/or 343 
functional alterations of kinetochore and centromeric proteins have been widely implicated in 344 
the promotion of chromosome mis-segregation and aneuploidy [32, 33]. WGS and RNA-seq 345 
analyses coupled with analysis of kinetochore protein expression by Western blot and 346 
immunofluorescence revealed a number of copy number alterations and abnormal levels of 347 
numerous important constituents of the inner and outer kinetochore (Fig. 8). Notably, our 348 
findings highlighted clear imbalances in the abundance of kinetochore proteins in BE and EAC 349 
cells. For example, both Western blot and immunofluorescence analyses indicated that the 350 
stoichiometry of the Ndc80 complex subunits Ndc80 and Spc24 was altered, as in most cases 351 
Ndc80 was more abundant than Spc24 in CPD and EAC cells (Fig. 6). Ndc80 overexpression has 352 
previously been described in brain, liver, breast, and lung cancers and increase in total Ndc80 353 
translated into increased accumulation of this protein at the kinetochore in human colorectal 354 
carcinoma (HCT116), colorectal adenocarcinoma (HT29), osteosarcoma (U2OS) and cervix 355 
adenocarcinoma (HeLa) cells [34, 35]. These findings led to speculate that increased 356 
accumulation of Ndc80, as part of the Ndc80 complex, might influence the interaction between 357 
kinetochores and microtubules in cancer cells. Our findings also support a similar conclusion 358 
that an increase of Ndc80 in EAC cells might be responsible for the chromosome alignment 359 
defects observed in these cells (Figs. 1 and 2). In addition, increase in Ndc80 was associated 360 
with a decrease in AURKB in both CPD and FLO cells (Figs. 6 and 8). The combination of 361 
reduced AURKB and Ndc80 overexpression could result in low Ndc80 phosphorylation and the 362 
formation of hyperstable kinetochore microtubule attachments and consequent problems in 363 
chromosome congression. Furthermore, the reduced levels of AURKB and BubR1 might 364 
weaken the SAC and allow mitotic slippage.  It is important to point out that these alterations 365 
cause subtle changes in the regulation and mechanics of chromosome dynamics, which would 366 
allow most mitoses to progress normally. However, in a few cases these changes could lead to 367 
polyploidy and CIN, thereby promoting the evolution and diversification of new clones with 368 
potentially advantageous characteristics. Moreover, chromosome segregation defects could 369 
also in turn lead to additional changes in the copy number and expression of other mitotic and 370 
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non-mitotic genes creating a self-feeding loop that would further refine the carcinogenic 371 
potential and adaptability of the clones over time and in response to specific selective 372 
pressures.    373 
Our findings also indicated that the Mis12 component Dsn1 was amplified and expressed 374 
at high levels in both EAC cultured cells and tumors, but paradoxically its accumulation at 375 
kinetochore in mitosis was reduced (Figs. 4, 6 and 8). We don’t have any explanation for this 376 
discrepancy at the moment, but these findings clearly indicate that a combination of different 377 
approaches - ranging from the analysis of genomes, transcriptomes, and proteomes down to 378 
the structure and composition of individual sub-cellular components - is necessary to fully 379 
evaluate the potential impact of gene and protein alterations in cancers.  380 
One question raised from our data is whether the scattered chromosome phenotype 381 
occurs just because of chromosome congression failure or also because of cohesion fatigue 382 
after a prolonged mitotic arrest. The evidence that EAC cells take significantly longer than CPA 383 
to align their chromosomes (Fig. 2) would suggest problems in chromosome congression, 384 
although we cannot exclude that EAC cells take longer to align their chromosomes because 385 
they are polyploid. Moreover, our time-lapse experiments indicated that some EAC cells 386 
showed problems in maintaining chromosome alignment after mitotic arrest (Fig. 2 and 387 
Supplementary movies 3 and 4), which would suggest that the spread of the chromosomes 388 
over the mitotic spindle might also result from cohesion fatigue. Future time lapse experiments 389 
using multiple fluorescent markers, such as tubulin and cyclin B, could help resolve this issue. 390 
Finally, our WGS analyses revealed that members of the PP1 family of phosphatases were 391 
frequently amplified in EAC cell lines, organoids, and tumors (Fig. 8). In particular, PPP1R1B, 392 
also known as DARPP-32, was one of the genes that showed the highest increase in copy 393 
number in EAC patients. DARPP-32 is a neuronal protein and a potent PP1 inhibitor [36]. 394 
Amplification of DARPP-32 and its truncated isoform t-DARPP has been found in 68% of gastric 395 
cancers and several studies indicated that it is also over-expressed in cancers of the breast, 396 
prostate, colon and esophagus - specifically in 30% of esophageal squamous cell carcinomas 397 
[37-43]. PP1 phosphatases antagonize the phosphorylation of many mitotic proteins by AURKB 398 
[44] and it is therefore tempting to speculate that their de-regulation could affect kinetochore-399 
microtubule attachments. Understanding how the PP1-AURKB regulatory balance is altered in 400 
EAC could provide extremely valuable insights for future targeted cancer therapies.  401 
 402 
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Materials and methods 403 
 404 
Cell culture 405 
Cell lines are listed in Supplementary Table S1 along with their characteristics, genetic 406 
information, origin, and source. RPE1 cells were cultured in Dulbecco’s Modified Eagle Medium 407 
Nutrient Mixture F12 (Life technologies) supplemented with 10% FBS (Sigma) and 1% 408 
pen/strep (ThermoFisher). CPA and CPD cells were cultured in Keratinocyte-SFM 409 
supplemented with 2.5 µg prequalified human Epidermal Growth Factor 1-53 (EGF) (Life 410 
technologies), 25 mg Bovine Pituitary Extract (BPE) (Life technologies) and 0.5% 411 
penicillin/streptomycin (pen/strep) (ThermoFisher). FLO cells were cultured in Dulbecco’s 412 
Modified Eagle Medium (DMEM) (Sigma) supplemented with 10% Fetal Bovine Serum (FBS) 413 
(Sigma) and 1% pen/strep (ThermoFisher). JH-Eso-AD1 cells were cultured in Minimum 414 
Essential Medium (MEM) (Sigma) supplemented with 10% FBS and 1% pen/strep 415 
(ThermoFisher). OE33 and OE19 cells were cultured in Roswell Park Memorial Institute (RPMI) 416 
Medium (Life technologies) supplemented with 10% FBS (Sigma) and 1% pen/strep 417 
(ThermoFisher).  All cells were cultured in a humidified atmosphere with 5% CO2 at 37°C. 418 
 419 
Organoid culture 420 
Organoids are listed in Supplementary Table S4 along with their characteristics and genetic 421 
information. Derivation and culture of organoids were recently described [20]. Briefly, for 422 
passaging organoids were washed with PBS, centrifuged and then disassociated by using 423 
TrypLE (Invitrogen) at 37 °C. The cell pellet was re-suspended in 7.5 mg/ml basement 424 
membrane matrix (Cultrex BME RGF type 2 - BME-2, Amsbio) and plated as 10–15 μl droplets. 425 
After BME-2 polymerized, complete media was added, and organoid culture left at 37 °C. All 426 
organoids have been passaged at least 25 times and grew for over 6 months. Organoids were 427 
evaluated with primary tumors at DNA, RNA and histological level to confirm their origin. 428 
 429 
Fluorescence microscopy  430 
Cells were grown on microscope glass coverslips (Menzel-Gläser) and fixed in either PHEM 431 
buffer (60 mM PIPES, 25 mM HEPES pH 7, 10 mM EGTA, 4 mM MgCl2, 3.7% [v/v] 432 
formaldehyde) for 12 min at room temperature or in ice-cold methanol for 10 min at -20°C. For 433 
astrin staining, coverslips were first incubated for 5 minutes in pre-extraction buffer (60 mM 434 
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PIPES pH 7.0, 25 mM HEPES pH 7.0, 10 mM EGTA, 4 mM MgSO4, 0.5 % [v/v] Triton X-100) and 435 
then fixed using PHEM buffer. After fixing, coverslips were washed three times for 10 min with 436 
PBS and incubated in blocking buffer (PBS, 0.5% [v/v] Triton X-100 and 5% [w/v] BSA) for 1 h at 437 
room temperature. Coverslips were incubated overnight at 4°C with the primary antibodies 438 
indicated in the figure legends, diluted in PBT (PBS, 0.1% [v/v] Triton X-100 and 1% [w/v] BSA). 439 
The day after, coverslips were washed twice for 5 min in PBT, incubated with secondary 440 
antibodies diluted in PBT for 2h at RT and then washed twice with PBT and once with PBS. 441 
Coverslips were mounted on SuperFrost Microscope Slides (VWR) using VECTASHIELD 442 
Mounting Medium containing DAPI (Vector Laboratories). Phenotypes were blindly scored by 443 
at least two people independently. Images were acquired using a Zeiss Axiovert 444 
epifluorescence microscope equipped with MetaMorph software. 445 
Organoids were cultured on chamber slide for 7 days and washed twice with PBS. Cultures 446 
were fixed in 4% PFA at room temperature, quenched with 100 mM glycine-PBS for 10 mins, 447 
permeabilized in PBS + 0.5% Triton X-100 for 20 minutes, followed by blocking buffer (PBS, 1% 448 
BSA [w/v]) for 1 hour, and then incubated at 4°C with primary antibodies. After overnight 449 
incubation, organoids were washed and incubated with appropriate secondary antibody for 1 450 
hour at room temperature as indicated above. Coverslips were mounted using VECTASHIELD 451 
Mounting Medium containing DAPI for nuclei staining. Organoids were imaged using a Leica 452 
confocal microscope TCS SP5, Z stacks were taken at 1-μm intervals and scored by two 453 
independent researchers. Images were processed by Volocity image analyse software (Perkin 454 
Elmer, version 6.3.0).   455 
Fiji [45] was used to generate maximum intensity projections, which were adjusted for 456 
contrast and brightness and assembled using Photoshop. Fluorescence intensity values of 457 
kinetochore proteins were calculated using Fiji software and the following formula:  (IK - IB) - (IC 458 
- IB) / (IC - IB) = (IK - IC) / (IC - IB), where IK = kinetochore intensity, IC = CREST intensity, and IB = 459 
background intensity. 460 
  461 
Time-lapse imaging  462 
Cells were plated on an 8 well µ slide (Ibidi) in their appropriate growth media. Prior to 463 
recording media was replaced with Leibovitz’s L-15 media (ThermoFisher) containing 0.5 μM 464 
SiR-DNA dye (SpiroChrome). Cells were incubated in the dark at 37°C for 20 minutes and then 465 
imaged on an Olympus IX83 with an LED illuminator (Spectra-X, Lumencor), XY automated 466 
 16
stage (ASI) in a 37°C incubation chamber (Digital Pixel) controlled using Micromanager 467 
freeware. Images were captured every 5 minutes for 100 frames with 100 ms brightfield and 468 
20 ms Cy5 exposure times. Further processing was carried out using Fiji [45]. 469 
 470 
Western blot 471 
Cells were centrifuged, resuspened in phosphate buffer saline (PBS) and then an equal volume 472 
of 2x  Laemmli buffer was added. Samples were then boiled for 10 min and stored at -20°C. 473 
Proteins were separated by SDS PAGE and then transferred onto PVDF membrane (Immobilon-474 
P) at 15V for 1 hour. Membranes were blocked overnight at 4°C in PBS + 0.1% (v/v) Tween 475 
(PBST) with 5% (v/v) dry milk powder. After blocking, membranes were washed once with PBST 476 
and then incubated with the appropriate primary antibody diluted in PBST + 3% (v/v) BSA 477 
(Sigma) for 2 hours at RT. Membranes were washed 3x5 minutes in PBST and then incubated 478 
with HRPA-conjugated secondary antibodies in PBST + 1% BSA for 1 hour at room temperature. 479 
After further 3x5 min washes in PBST, the signals were detected using the ECL West Pico 480 
substrate (ThermoFisher) and chemiluminescent signals were acquired below saturation levels 481 
using a G:BOX Chemi XRQ (Syngene) and quantified using Fiji [45].  482 
 483 
Antibodies 484 
The following antibodies and dilutions for Western blot (WB) and immuno-fluorescence (IF) 485 
were used in this study: mouse monoclonal anti α-tubulin (clone DM1A, Sigma, T9026; 486 
dilutions for WB 1:20000, for IF 1:2000), rabbit polyclonal anti-β-tubulin (Abcam, ab6046; 487 
dilutions for WB 1:5000, for IF 1:400), mouse monoclonal anti γ-tubulin (Sigma, GTU88; 488 
dilutions for IF 1:200), mouse monoclonal anti-cyclin B1 (Santa Cruz, clone GNS1, sc-245; 489 
dilution for WB 1:2000), mouse monoclonal anti-Aurora B (clone AIM-1, BD Transduction 490 
Laboratories, 611082; dilutions for WB 1:2000, for IF 1:100), rabbit polyclonal anti-phospho-491 
histone H3 pS10 (Merck, 06-570; dilution for WB 1:10000 for IF 1:500), rabbit polyclonal anti-492 
BubR1 (Abcam, ab172518; dilution for WB 1:10000, for IF 1:500), rabbit polyclonal anti-DSN1 493 
(Sigma, SAB2702119; dilution for WB 1:2000, for IF 1:100), human anti-CREST (Antibodies 494 
Incorporated, 15-234; dilution for IF 1:1000) rat polyclonal anti-Plk4 (kind gift from P. Almeida 495 
Coelho and D. M. Glover, University of Cambridge, UK; dilution for IF 1:1000), rabbit 496 
monoclonal anti-Spc24 (Abcam, ab169786; dilution for WB 1:2000, for IF 1:200), mouse 497 
monoclonal anti-Ndc80/Hec1 (Santa Cruz, sc-515550, dilution for WB 1:500, for IF 1:50), rabbit 498 
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polyclonal anti-astrin (Novus Biologicals, NB100-74638, dilution for IF 1:100). Peroxidase and 499 
Alexa-fluor conjugated secondary antibodies were purchased from Jackson Laboratories and 500 
ThermoFisher, respectively. 501 
 502 
Computational and statistical analyses 503 
Mutation and copy number calls for different BE and EAC cell lines as published [19] were used 504 
for analysis. Copy number calling was performed by FREEC [46], as described [19]. Mutations 505 
were called by GATK (Broad Institute, MA, USA), as described [19]. Amplifications were defined 506 
as genes with 2× the median copy number of the host chromosome or greater. 507 
To capture mutations and copy number alterations in EACs and primary organoids, we 508 
used WGS sequencing data of 379 EAC cases from the Oesophageal Cancer Clinical And 509 
Molecular Stratification (OCCAMS) consortium [9]. We used final calls available for these 510 
datasets, where Strelka [47] was applied for calling SNVs/small indels and ASCAT  [48] for copy 511 
number alterations. Genes were tagged as amplified if ploidy adjusted CN >2 and <10 or 512 
extrachromosomal-like if their ploidy adjusted CN >10. Along with WGS data, matched RNA-513 
seq for subset of cases was used for transcriptomic analysis . We used processed expression 514 
quantification measured as Transcripts per Million (TPM) for analysis [9]. Both genomic 515 
alterations and transcriptomic analysis was restricted to a set of annotated kinetochore-516 
related genes (Supplementary Table S3). Only genes altered in at least 3% of cases were 517 
reported. To check whether amplification correlate with expression, we compared expression 518 
of the target gene between cases without alterations and cases with amplification; level of 519 
significance was measured by non-parametric Wilcoxon test. 520 
We ran single sample based gene set enrichment method to measure enrichment of 521 
annotated gene signatures (collection of genes). In this case we used known annotated 522 
hallmark gene signatures [49] related to cell cycle along with our annotated kinetochore genes 523 
and measured their enrichment across all EAC cases with RNA-seq data available using GSVA 524 
[50]. 525 
Unless otherwise specified, Prism8 (GraphPad) and Excel (Microsoft) were used for 526 
statistical analyses and to prepare graphs. 527 
 528 
Availability of Data and Materials 529 
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The WGS and RNAseq data of the EAC primary tumors and BE and EAC cell lines were 530 
published before and deposited at the European Genome-phenome Archive (EGA); accession 531 
numbers can be found in the relative publications cited in the text . The RNAseq and WGS data 532 
of the organoid lines have been deposited at the EGA under accession number 533 
EGAD00001006738.  534 
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Figure Legends 693 
 694 
Fig. 1.  BE and EAC cells displays specific mitotic defects. (a) Cells from representative BE and 695 
OAC cell lines were stained to detect the mitotic marker histone H3 pS10, tubulin and DNA (see 696 
F and G below). The percentages of cells in mitosis (mitotic indices) were counted (a) and 697 
categorized by each mitotic stage (b) through visual analysis of the presence of H3 pS10 and 698 
characteristic mitotic figures. In addition, for each cell line the number of abnormal mitoses 699 
was also counted (c) and categorized into one of three phenotypes: lagging chromatin, 700 
multipolar spindles or scattered chromosomes (e). (d) Graph showing the percentages of 701 
multinucleate cells from the experiments described in (a-g). More than 3000 cells in total and 702 
more than 200 mitotic cells per each cell line were counted; n≥6 independent experiments; * 703 
p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 (Mann–Whitney U test). Two-way ANOVA 704 
statistical analyses with multiple comparisons of the data in (B) and (E) are shown in 705 
Supplementary Table S2 and S3, respectively. To improve visualization, only the summary of 706 
the data is shown in (E), but a similar graph including also the individual values is shown in 707 
Supplementary Fig. S1. In each graph, bars indicate SEM. (f-g) Representative images from the 708 
indicated BE and OAC cell lines fixed and stained to detect  the mitotic marker histone H3 pS10 709 
(red in the merged images), tubulin (green in the merged images) and DNA (blue in the merged 710 
images). Bars, 10 μm. 711 
 712 
Fig. 2. EAC cells have problems in congressing and aligning chromosomes and display mitotic 713 
slippage. (a-d) Images from time-lapse recordings of the indicated BE and EAC cells treated 714 
with SiR-DNA dye to visualize chromosome dynamics. Images were captured at 5 minutes 715 
intervals for 8-10 hours. Time is in min:sec relative to nuclear envelope breakdown (NEB). The 716 
arrows in (b) mark lagging chromatin. Bar, 10 µm. (e) Graph showing the frequency of 717 
phenotypes observed in the time-lapse recordings described in (a-d). 30 independent CPA 718 
cells, 18 independent FLO cells, and 7 independent JH-Eso-AD1 cells were analyzed. (f) Scatter 719 
plots showing quantification of the length of mitosis (from NEB until telophase) and the length 720 
of prometaphase-anaphase (from NEB until anaphase onset). n= 15 for CPA cells, n=12 for FLO 721 
cells, and n= 5 for  JH-Eso-AD1 cells; *** p < 0.001, **** p < 0.0001 (Mann–Whitney U test).  722 
 723 
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Fig. 3. EAC organoids display mitotic defects similar to EAC cultured cells. (a) The indicated 724 
control and EAC organoids were fixed and stained to detect tubulin (red in the merged 725 
images), the centromeric marker CREST (green in the merged images), and DNA (blue in the 726 
merged images). Bars, 10 µm. (b) Graph showing the quantification of mitotic defects observed 727 
in the indicated organoids; 20 organoids in 2 independent experiments were analyzed for each 728 
group. (c) Graph showing the frequency of phenotypes observed in the organoids described in 729 
(a-b).   730 
 731 
Fig. 4. Genes involved in chromosome attachments are altered in EAC cells, organoids, and 732 
tumors. Diagrams showing the frequency and nature of SNVs, indels, and copy number 733 
alterations of genes involved in chromosome attachment in cell lines and organoids (a), and 734 
EAC cases (n=379) from the Oesophageal Cancer Clinical And Molecular Stratification 735 
(OCCAMS) consortium (b). Total proportion of cases altered by individual gene are listed at the 736 
bottom (a) or at the left (b) of the oncoplot. 737 
 738 
Fig. 5.  The expression of genes involved in chromosome attachments is altered in EAC 739 
tumors. (a) Graphs illustrating expression levels measured in log transformed Transcripts Per 740 
Million (TPM) for genes PPP1R1B, DSN1, and MAD2L1BP across EAC cases with different 741 
alteration types showing significant increase in expression upon amplification as compared to 742 
control wild type (WT) cases. (p-values computed through Wilcoxon test). (b) RNA-seq based 743 
single sample geneset enrichment analysis of annotated gene signatures across EAC cases 744 
(n=145) shows co-enrichment of our kinetochore gene signature (Supplementary Table S5) 745 
with known cell-cycle hallmark gene signature [49]. 746 
 747 
Fig. 6. Kinetochore protein levels are altered in dysplastic BE and EAC cells. (a) Analysis of 748 
protein expression in BE (CPA and CPD) and EAC cells (FLO and JH-Eso-AD1). Proteins extracts 749 
from the indicated BE and EAC cells were separated by SDS PAGE and analyzed by Western blot 750 
to identify the proteins indicated to the right. The numbers on the left indicate the sizes of the 751 
molecular mass marker. The graph at the bottom shows the quantification of protein levels, 752 
normalized to tubulin and relative to levels in CPA cells. (b-f) Indicated BE and EAC cells were 753 
fixed and stained to detect the indicated epitopes. The insets show a 5x magnification of 754 
selected kinetochores. Bars, 10 µm. In each panel, the graphs to the right show quantification 755 
 24
of fluorescence levels normalized to the centromere marker CREST (see Methods). More than 756 
25 kinetochores from cells with aligned chromosomes and at least 10 kinetochores from cells 757 
with scattered (S) chromosomes were counted in n≥3 independent experiments. Horizontal 758 
bars indicate medians; **** p < 0.0001, *** p < 0.001 (two-tailed unpaired student’s T-test).  759 
 760 
Fig. 7. FLO cells with scattered chromosomes display an increase in lateral kinetochore-761 
microtubule attachments. (a) CPA and FLO cells were fixed and stained to detect the indicated 762 
epitopes. The insets show a 5x magnification of selected kinetochores. Bars, 10 µm. (b) Graph 763 
showing the quantification of lateral kinetochore-microtubule attachments in CPA and FLO 764 
cells. 100 kinetochores were counted in each group; n=11 independent CPA cells, n=10 765 
independent FLO cells and n=9 independent FLO cells with scattered chromosomes (S). Bars 766 
indicate standard errors; * p < 0.05 (Mann–Whitney U test). 767 
 768 
Fig. 8.  Alteration in genes and proteins involved in chromosome attachments identified in 769 
this study.  Schematic diagram illustrating the different kinetochore layers and summarizing 770 
the different type of alterations for each specific gene and corresponding protein found in our 771 
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Videos S1 to S4 





Supplementary Figure Legends 
 
Figure S1.  BE and EAC cells displays specific mitotic defects. Graph showing the percentages 
of BE and OAC cells showing one of three phenotypes: lagging chromatin, multipolar spindles 
or scattered chromosomes. Bars indicated SEM. More than 3000 cells in total and more than 
200 mitotic cells per each cell line were counted; n≥6 independent experiments.  
 
Figure S2. EAC cells display extra centrosomes. (a) Representative images from the indicated 
BE and EAC cell lines fixed and stained to detect Plk4 (red in the merged images), g-tubulin 
(green in the merged images) and DNA (blue in the merged images). Bars,  10 µm. (b-c) Graphs 
showing the quantification of the number of centrosomes (B) and the defects (C) observed in 
in the mitotic cells from the experiments in (A). At least 50 mitotic figures from at least 3 
different experiments were analyzed for each cell line.  Bars indicated SEM; **** p<0.0001 
(Two-way ANOVA with multiple comparisons). 
 
Figure S3. BE and EAC cells have a functional spindle assembly checkpoint. (a) Indicated BE 
and EAC cells were treated with the microtubule depolymerizing drug nocodazole or its 
solvent DMSO for 18 hours and then fixed and stained to detect  the mitotic marker histone 
H3 pS10 (red in the merged images), tubulin (green in the merged images) and DNA (blue in 
the merged images). Bars,  10 µm. (b) Graph showing the quantification of cells in mitosis 
(mitotic indices; MI) for each cell line from the experiment described in (A). (c) Graph showing 
the MI fold increase for each cell line from the experiment described in (A). More than 1500 
cells were counted for each cell line; n≥3 independent experiments. 
 
Figure S4. EAC organoids. Phase contrast images of the organoids used in the experiments 
shown in Fig. 3.  Bars, 50 µm.   
 3 




Origin Gender Age Ploidy p53  Reference 
/source 
RPE1 Retinal epithelium, h-
TERT immortalised 
Female  Adult Diploid Wild type [1]/ATCC 
CPA Non dysplastic BE, h-
TERT immortalised 
Male  Adult Near 
diploid 
Wild type [2]/ATTC 
CPD Dysplastic BE, h-TERT 
immortalised 
Male Adult Near 
tetraploid 
c.404G>A [2]/ATTC 





EAC stage 3, 
moderate to poor 
differentiation 
Male 66 Near 
tetraploid 
c.797G>A [4]/to be 
deposited 
to ATCC 
OE19 EAC stage 2, 
moderate 
differentiation 
Male 72 Near 
tetraploid 
c.929dup [5]/EACC 
OE33 EAC stage 2, poor 
differentiation 









Table S4. List of organoids used in our analyses. 
 
IDs Age Gender Differentiation p53 status Ploidy 
NG088 76 Male Moderate Wild type Not known, but likely 
diploid 
CAM277 80 Female Poor c.414delG, loss of 
p53 expression at 
protein level 
Tetraploid genome, 100% 
of metaphases have a 
ploidy of >55. Ploidy of 
4.04 indicating this 
organoid has experienced 
WGD. 
CAM401 77 Female Poor Over-expressed 
p53 with hotspot 
mutation (R175H) 
Aneuploid genome, ploidy 
of 1.74. Analysis of 
metaphases showed the 
following ploidy results: ~ 
90% <40, ~5% 41-45 and 
~5% 47-55.  
CAM408 60 Male Moderate c.586G>A, loss of 
p53 expression at 
protein level 
Aneuploid genome, 
analysis of metaphases 
showed the following 
ploidy results: ~10% <40, 
~70% 41-45, ~5% 46 and 
~5% >55. Overall ploidy 
score 1.94 
CAM486 72 Male Moderate Over-expressed 
p53 with mutation 
C.731C>T 
Not determined 
CAM423 55 Male Moderate to 
poor 
Wild type TP53 
and p53 
expression pattern 
Tetraploid genome. Ploidy 
4.48 indicating this 
organoid has experienced 
WGD 
 
NG088 is the control organoid derived from non-cancerous cells from the stomach, the other 
organoids are all derived from EACs. All cultures are mixed heterogenous populations 
composed of cells with a variety of changes in chromosome number as well as chromosome 
rearrangements [6]. 
 
Other Supplementary Table Legends 
Supplementary Table S2.   
Two-way ANOVA statistical analysis of the data relative to the graph shown in Fig. 1B. Multiple 
comparisons are shown in a separate sheet. 
 
Supplementary Table S3. 
Two-way ANOVA statistical analysis of the data relative to the graph shown in Fig. 1E. Multiple 
comparisons are shown in a separate sheet. 
 
Supplementary Table S5. 
 5 
List of the genes involved in chromosome attachment selected for WGS and RNAseq analyses. 
For each gene is shown the primary gene name, entry UNIPROT ID, Ensembl ID, protein name 
and GO annotations. 
 
Supplementary Movie Captions 
Supplementary Movie S1. 
This movie shows chromosome dynamics, visualized using SiR-DNA, in a CPA cell. All 
sequences were captured at 5 min intervals. Playback rate is 5 frames per second (FPS). 
Supplementary Movie S2. 
This movie shows chromosome dynamics, visualized using SiR-DNA, in a FLO cell. This cell 
completed mitosis, but showed lagging chromatin. All sequences were captured at 5 min 
intervals. Playback rate is 5 frames per second (FPS). 
Supplementary Movie S3. 
This movie shows chromosome dynamics, visualized using SiR-DNA, in a FLO cell. This cell 
failed to complete mitosis after an initial attempt to enter anaphase, and then chromosomes 
started to drift and decondense, indicating mitotic slippage. All sequences were captured at 
5 min intervals. Playback rate is 5 frames per second (FPS). 
Supplementary Movie S4. 
This movie shows chromosome dynamics, visualized using SiR-DNA, in a JH-Eso-AD1  cell. This 
cell failed to complete mitosis after an initial attempt to enter anaphase, and then 
chromosomes started to drift and decondense, indicating mitotic slippage. All sequences 
were captured at 5 min intervals. Playback rate is 5 frames per second (FPS). 
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